An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Editorial by Βy Prof. Daniele Regge, Chief of the Radiology Unit, Candiolo Cancer Institute (FPO) The Clinical Vision of the project and added value for patients One man in eight is diagnosed with prostate cancer during his lifetime and among them, approximately one...
By Prof Mu Koh, Royal Marsden NHS Foundation Trust (ICR) Primary prostate cancer is a heterogeneous disease in terms of disease aggressiveness and long-term outcomes. Many men who are diagnosed with prostate cancer will have indolent disease and die of other causes....
By Prof Jurgen Futterer & Prof Henkjan Huisman, RadboudUMC (RUN) Professors Jurgen Futterer and Henkjan Huisman are both affiliated with Radboudumc, Nijmegen, The Netherlands. They have a long-standing collaboration and are part of the EU H2020 project ProCAncer-I...
By Joao Correia, Innovation Manager at Biotronics3D Limited (B3D) The ProCAncer-I eCRF (electronic case report form) and Data Upload Tools support ProCAncer-I clinical partners in the process of compiling the required information and follow the defined protocols for...
By Theresa Henne, University of Vienna (UNIVIE), Clara Saillant University of Vienna (UNIVIE) &Varvara Kalokyri, Foundation for Research and Technology (FORTH) Data is increasingly regarded as a valuable resource, in particular for the development of Big Data and...
Biotronics3D was established in 2004 in London, opened an R&D Centre in Cambridge in 2009, opened a Central European Operations office in Bucharest in 2014, and established its Innovation Centre in Edinburgh during 2017. Biotronics3D recently integrated the...
The Girona Biomedical Research Institute (IDIBGI) aims to promote translational research to improve people's health. Located in Girona area, in Catalonia (Spain), its activity aims to increase knowledge of numerous diseases to improve their diagnosis, treatment and...
Newsletter #4 Contents
ProCAncer-I is part of the European Federation for Cancer Images (EUCAIM) project and the European Cancer Imaging Initiative
The Commission is organising a hybrid event on 23 January 2023 in Brussels to mark the launch of the Cancer Imaging Initiative, one of the Flagship Initiatives of the Europe’s Beating Cancer Plan. This 2.5-hour event will present the policy background and the Cancer...
The ProCAncer-I project participated at the “Current Developments in Radiology” conference, organized by the Hellenic Radiological Society. The conference was held on December 09-11, 2022 in Athens, Greece at Divani Caravel Hotel. During the Conference, which was...
Our Scientific Manager, Dr Nickolas Papanikolaou was at the 108th Scientific Assembly and Annual meeting (Chicago 27-30/11/2022). The panel discussion included Dr Mona Flores, Global Head of Medical AI at NVIDIA, and Dr Nikos Papanikolaou, Computational Clinical...
The #EUCAIM project originates from the work and expertise of the AI for Health Imaging Network (AI4HI), composed of INCISIVE, @chaimeleon_eu, @EuCanImage, @ProCAncer_I and @primage_project. #EUCancerImaging #DigitalEU #EUCancerPlan https://digital-strategy.ec.europa.eu/en/policies/cancer-imaging
Proud to be part of the #EUCAIM project led by @EIBIR_biomed, supporting the #EUCancerImaging Initiative by contributing to an infrastructure of Cancer #images and development & benchmarking of AI tools with #EuroBioImaging Nodes & many other partners.
https://www.eurobioimaging.eu/news/proud-to-be-part-of-the-eucaim-project-/
The launch of #EUCancerImaging Initiative will boost innovative cancer diagnostics and treatment and make screening more precise and accessible.
It shows the potential of digital solutions that can bring hope to cancer patients and their families.
#EUCancerPlan
